Today

Technological innovations

Prélèvement d’un échantillon de culture cellulaire en suspension en bioréacteur

Today, Genethon is conducting, alone or in partnership with international excellence teams, several projects for the development of therapies for rare diseases, affecting muscles, immune system, blood, liver and vision.

In 2012 Genethon received the Prix Galien France for pharmaceutical research into “Medicines destined for rare diseases – cell therapy and gene therapy” and in 2015 Genethon was the recipient of the Global Innovation Competition 2030.

 

Read the press releases :